Mumbai, India

Edmund Carvalho


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Edmund Carvalho

Introduction

Edmund Carvalho is a notable inventor based in Mumbai, India. He has made significant contributions to the field of ocular health through his innovative patents. With a total of two patents to his name, Carvalho's work focuses on developing advanced solutions for ocular diseases.

Latest Patents

Carvalho's latest patents include the development of nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases. This technology provides a nanoparticulate in-situ gelling vitreous substitute that remains a liquid at room temperature, facilitating easy administration through a small needle incision. Once inside the eye, it forms a gel that is hydrophilic in nature, mimicking the properties of natural vitreous humor. The formulation may consist of a water-soluble natural or synthetic polymer and a gelling agent, blended in the presence of a cross-linker to create a gel with the desired properties. The cross-linking and gelation process can occur in-situ, achieved by dispensing the components of the vitreous substitute in liquid form along with the cross-linking agent. Another patent focuses on nanoparticulate in-situ gels of TPGS, gellan, and PVA as vitreous humor substitutes, showcasing similar innovative features and applications.

Career Highlights

Edmund Carvalho is affiliated with the Indian Institute of Technology Bombay, where he continues to contribute to research and development in the field of ocular health. His work is characterized by a commitment to advancing medical technology and improving patient outcomes.

Collaborations

Carvalho collaborates with Rinti Banerjee, enhancing the scope and impact of his research initiatives.

Conclusion

Edmund Carvalho's innovative patents represent significant advancements in ocular health technology. His contributions are poised to make a lasting impact on the treatment of ocular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…